The Connell and O'Reilly Families Cell Manipulation Core Facility (CMCF) assists DF/HCC members in developing new cell-based therapies for patients with cancer who are enrolled in novel therapeutic clinical research protocols. Key ServicesCore services include processing of hematopoietic stem cells for autologous or allogeneic transplantation, genetic modification of hematopoietic stem cells, gene